09/01/2015 - 9:46am

The company said the patch is a potential solution for the 73% of migraine sufferers who experience nausea with their migraines. 

08/25/2015 - 11:43am

Amneal Pharmaceuticals announced Tuesday that it would be opening a new biosciences unit, that will be focused on commercializing specialty pharmaceuticals. 

08/25/2015 - 11:11am

The drug can be used in children 1 year of age and older with ITP who have not had a sufficient response to a splenectomy, immunoglobulins or corticosteroids.

08/24/2015 - 5:33pm

After years of research and billions of dollars in funding, the Human Genome Project has unlocked the complex mysteries of the human genome and unleashed a new era in personalized medicine and pharmaceutical research and development. And pharmacy retailers must get out in front of that gene-based drug revolution or risk being left behind.

08/21/2015 - 12:11pm

Diplomat Pharmacy’s summer internship and fellowship program saw 10 fellows and 25 interns spend 12 weeks gaining hands-on experience in different departments of the specialty pharmacy. 

08/14/2015 - 11:08am

Keveyis is the first medicine approved by the FDA for the treatment of primary periodic paralysis, which is estimated to affect approximately 5,000 people in the United States.

08/14/2015 - 10:55am

The research project will provide pharmacogenomics services in community pharmacies including collection of DNA samples, interpretation of patient results, counseling and collaboration with prescribers. 

08/12/2015 - 3:14pm

BioPlus is now one of over 70 founding and corporate members of NASP.

08/11/2015 - 3:02pm

Iressa is a once-daily oral medication that targets and blocks the activity of epidermal growth factor receptor-tyrosine kinase.